(Q36303910)

13 August 2017

1 reference

title

Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer (English)

1 reference

13 August 2017

0 references

2

Lori A Pollack

1 reference

13 August 2017

Lisa C Richardson

1

1 reference

13 August 2017

publication date

1 January 2005

1 reference

Nature Clinical Practice Oncology

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

48-53

1 reference

The need for a multidisciplinary approach to cancer care

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

The management of diabetes in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Abnormal glucose tolerance and the risk of cancer death in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Colorectal cancer: another complication of diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Cancer risk in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Role of diabetes mellitus in the etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Reduced risk of prostate cancer among patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Diabetic cardiomyopathy: a metabolic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

ABC of arterial and venous disease: vascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Cancer survivors in the United States: age, health, and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

Nutrition, insulin, insulin-like growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

A prospective study of plasma C-peptide and colorectal cancer risk in men

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Pharmacology of Anticancer Drugs in the Elderly Population

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Dose-response effect of adjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPONC0062

1 reference

7 January 2021

Cardiac effects of adjuvant therapy for early breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Impact of diabetes mellitus on outcomes in patients with colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Diabetes and the risk of infection-related mortality in the U.S.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Hyperglycemic complications associated with adjuvant chemotherapy of breast cancer. A cancer and leukemia group B (CALGB) study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Unrecognized diabetes among hospitalized patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Early detection of undiagnosed diabetes mellitus: a US perspective

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Mortality from site-specific malignancies in type 2 diabetic patients from Verona

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

How to calculate the dose of chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Subclinical states of glucose intolerance and risk of death in the U.S.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Preventing cancer, cardiovascular disease, and diabetes: a common agenda for theAmerican Cancer Society, the American Diabetes Association, and the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0062

7 January 2021

Identifiers

DOI

10.1038/NCPONC0062

1 reference

Dimensions Publication ID

13 August 2017

1044449437

0 references

1 reference